检索结果 - Flavia Di Nucci
- Showing 1 - 4 results of 4
-
1
Genetic variation associated with thyroid autoimmunity shapes the systemic immune response to PD-1 checkpoint blockade 由 Zia Khan, Christian Hammer, Jonathan Carroll, Flavia Di Nucci, Sergio Ley Acosta, Vidya Maiya, Tushar Bhangale, Julie Hunkapiller, Ira Mellman, Matthew L. Albert, Mark I. McCarthy, G. Scott Chandler
出版 2021Artigo -
2
Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer 由 Zia Khan, Flavia Di Nucci, Antonia Kwan, Christian Hammer, Sanjeev Mariathasan, Vincent Rouilly, Jonathan Carroll, Magnus Fontes, Sergio Ley Acosta, Ellie Guardino, Haiyin Chen‐Harris, Tushar Bhangale, Ira Mellman, Jonathan E. Rosenberg, Thomas Powles, Julie Hunkapiller, G. Scott Chandler, Matthew L. Albert
出版 2020Artigo -
3
Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma 由 Yohann Loriot, Cora N. Sternberg, Daniel Castellano, Sjoukje F. Oosting, Herlinde Dumez, Robert Huddart, Karina Vianna, Teresa Alonso Gordoa, Iwona Skoneczna, André P. Fay, Franco Nolé, Francesco Massari, Birutė Brasiūnienė, Pablo Maroto, Simon Fear, Flavia Di Nucci, Sabine de Ducla, Ernest Choy
出版 2020Artigo -
4
Safety and efficacy of atezolizumab (atezo) in patients (pts) with autoimmune disease (AID): Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcin... 由 Yohann Loriot, Cora N. Sternberg, D. Castellano Gauna, Herlinde Dumez, Robert Huddart, Karina Vianna, Teresa Alonso Gordoa, Iwona Skoneczna, AP Fay, Cosimo Sacco, Franco Nolè, Francesco Massari, Birute Brasiūnienė, Pablo Maroto, Sjoukje F. Oosting, Simon Fear, Flavia Di Nucci, Sabine de Ducla, Ernest Choy
出版 2019Artigo
相关主题
Atezolizumab
Immunotherapy
Internal medicine
Medicine
Oncology
Cancer
Nivolumab
Adverse effect
Autoimmunity
Immune checkpoint
Immune system
Immunology
Subgroup analysis
Biology
Bladder cancer
Blockade
Clinical endpoint
Clinical trial
Confidence interval
Discontinuation
Environmental health
Gene
Genetics
Genome-wide association study
Genotype
Meta-analysis
Pembrolizumab
Population
Psoriasis
Receptor